- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04854694
Product Testing of the FaceView Mask™: Usability Survey
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
A goal of 200 participants is desired with a minimum of 125 to meet study targets. We will be contacting known persons (not cold contacts) with ability to share study brochure by e-mail:
- across the UAMS campus (e.g., College Deans, Center Directors, Program Directors);
- surrounding clinics;
- American Sign Language interpreter education at the University of Arkansas at Little Rock (Program Director)
- Arkansas School for the Deaf (Superintendent and/or Assistant to the Superintendent); and
- Communications Plus+ Interpreter Services, Inc. (owner and operator)
Description
Inclusion Criteria:
- at least 18 years old
- have no health conditions that would prevent them from safely wearing an N95 respirator (e.g., severe asthma, chronic obstructive pulmonary disease)
- read in English and communicate in English or American Sign Language
- be able to provide or arrange their own transportation to the study location
Exclusion Criteria:
- Children are to be excluded from the proposed research project because the current FaceView Mask™ is designed for adults
- Adults who are non-English communicators
- Any adult with health conditions that would prevent them from safely wearing an N95 respirator (e.g., severe asthma, chronic obstructive pulmonary disease)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
All Subjects
All participants will be fit tested for the masks to ensure that the appropriate size is used. Some participants will wear the FaceView Mask™ (first) for 5 minutes before wearing the conventional surgical N95 respirator for 5 minutes. Others will wear the conventional surgical N95 respirator (first) for 5 minutes before wearing the FaceView Mask™ for 5 minutes. All subjects will complete the study survey after exposure to the interventions. |
transparent surgical N95 respirator designed to improve communication
standard N95 respirator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ease of Understanding Another Person
Time Frame: 1 day
|
As recorded on the survey
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fit of the Mask
Time Frame: 1 day
|
As recorded on the survey
|
1 day
|
|
Comfort of the Mask
Time Frame: 1 day
|
As recorded on the survey
|
1 day
|
|
Ease of Breathing
Time Frame: 1 day
|
As recorded on the survey
|
1 day
|
|
Ease of Speaking/Communicating
Time Frame: 1 day
|
As recorded on the survey
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Samuel R Atcherson, PhD, University of Arkansas
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 262478
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Disability
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenActive, not recruitingHearing DisabilityBelgium
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompleted
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingHearing DisabilityBelgium
-
Çankırı Karatekin UniversityNot yet recruitingHearing Disability | Human Papilloma Virus (HPV)
-
King Faisal UniversityCompletedHearing Disability | Hard of Hearing | DeafSaudi Arabia
-
University of North Carolina, Chapel HillMed-El CorporationWithdrawnHearing Loss | Hearing DisabilityUnited States
-
University of ExtremaduraUniversity of CadizCompletedDisability Physical | Disabilities Multiple | Disability, Intellectual | Disability Hearing | Disability, VisionSpain
-
Region SkaneHorselvarden Region OstergotlandActive, not recruitingOtorhinolaryngologic Diseases | Ear Diseases | Sensation Disorders | Hearing Loss | Hearing Disorders | Hearing Impairment | Hearing DisabilitySweden
-
Ottawa Hospital Research InstituteAdvanced BionicsUnknownHearing Disability | Cochlear Implant | Hearing Disorders and DeafnessCanada
-
University of South FloridaCompletedHearing Disability | Hearing Loss, Age-Related | Presbycusis, BilateralUnited States
Clinical Trials on FaceView Mask™
-
Charles University, Czech RepublicMilitary University Hospital, PragueRecruitingAirway Management | Anesthesia | Tracheal IntubationCzechia
-
Catholic University of the Sacred HeartCompletedRespiratory FailureItaly
-
Ondokuz Mayıs UniversityCompleted
-
Papworth Hospital NHS Foundation TrustCompletedCardiac SurgeryUnited Kingdom
-
Dokuz Eylul UniversityCompleted
-
Hospital Sao JoaoWithdrawnLung Disease | Acute Respiratory Distress SyndromePortugal
-
Ankara City Hospital BilkentNot yet recruitingAirway Management | Shoulder Surgery | Supraglottic Airway | General AnestheticTurkey (Türkiye)
-
Kasr El Aini HospitalCompleted
-
Changi General HospitalCompleted
-
M.D. Anderson Cancer CenterAmbu A/SCompletedAnesthesiaUnited States